1. Home
  2. RGC vs FBLG Comparison

RGC vs FBLG Comparison

Compare RGC & FBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGC
  • FBLG
  • Stock Information
  • Founded
  • RGC 2014
  • FBLG 2021
  • Country
  • RGC Hong Kong
  • FBLG United States
  • Employees
  • RGC N/A
  • FBLG N/A
  • Industry
  • RGC Medicinal Chemicals and Botanical Products
  • FBLG
  • Sector
  • RGC Health Care
  • FBLG
  • Exchange
  • RGC Nasdaq
  • FBLG NYSE
  • Market Cap
  • RGC 105.3M
  • FBLG 91.0M
  • IPO Year
  • RGC 2021
  • FBLG 2024
  • Fundamental
  • Price
  • RGC $4.86
  • FBLG $1.88
  • Analyst Decision
  • RGC
  • FBLG Strong Buy
  • Analyst Count
  • RGC 0
  • FBLG 4
  • Target Price
  • RGC N/A
  • FBLG $13.00
  • AVG Volume (30 Days)
  • RGC 8.8K
  • FBLG 138.6K
  • Earning Date
  • RGC 10-25-2024
  • FBLG 02-02-2025
  • Dividend Yield
  • RGC N/A
  • FBLG N/A
  • EPS Growth
  • RGC N/A
  • FBLG N/A
  • EPS
  • RGC N/A
  • FBLG N/A
  • Revenue
  • RGC N/A
  • FBLG N/A
  • Revenue This Year
  • RGC N/A
  • FBLG N/A
  • Revenue Next Year
  • RGC N/A
  • FBLG N/A
  • P/E Ratio
  • RGC N/A
  • FBLG N/A
  • Revenue Growth
  • RGC N/A
  • FBLG N/A
  • 52 Week Low
  • RGC $3.03
  • FBLG $1.08
  • 52 Week High
  • RGC $32.44
  • FBLG $46.00
  • Technical
  • Relative Strength Index (RSI)
  • RGC 44.96
  • FBLG 39.10
  • Support Level
  • RGC $4.75
  • FBLG $1.86
  • Resistance Level
  • RGC $5.21
  • FBLG $2.34
  • Average True Range (ATR)
  • RGC 0.30
  • FBLG 0.24
  • MACD
  • RGC 0.04
  • FBLG -0.01
  • Stochastic Oscillator
  • RGC 23.87
  • FBLG 3.08

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

About FBLG FIBROBIOLOGICS INC

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Share on Social Networks: